Dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin) enhances triggered afterdepolarizations in rat ventricular myocytes

Cardiovascular Toxicology

Volumn 6, Issue 2, 2006, Pages 99-110

  Xie, An ^a,d   Walker, Nigel J ^b   Wang, Desuo ^a,c  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c University of Chicago ^*  (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Afterdepolarizations; Cardiac action potential; TCDD; Transient outward current; Triggered activity; Ventricular arrhythmia

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CALCIUM CHANNEL L TYPE; ISOPRENALINE; NYSTATIN;

AMPLITUDE MODULATION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CALCIUM SIGNALING; CARDIOTOXICITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HEART DEPOLARIZATION; HEART MUSCLE CELL; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TOXICITY TESTING; VOLTAGE CLAMP;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ACTION POTENTIALS; ADRENERGIC BETA-AGONISTS; ANIMALS; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNELS, L-TYPE; CELL SEPARATION; FEMALE; HEART VENTRICLES; ISOPROTERENOL; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; TETRACHLORODIBENZODIOXIN;

ITI; RATTUS;

EID: 33847167029     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/CT:6:2:99     Document Type: Article

References (59)

1. Poland, A. and Knutson, J.C. (1982). 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22:517-554.
2. Schmidt, J.V. and Bradfield, C.A. (1996). Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12:55-89.
3. Gilday, D., Gannon, M., Yutzey, K., Bader, D., and Rifkind, A.B. (1996). Molecular cloning and expression of two novel avian cytochrome P450 1A enzymes induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 271(51):33,054-33,059.
4. Cole, P., Trichopoulus, D., Pastides, H., Starr, T., and Mandel, J. (2003). Dioxin and cancer: a critical review. Regul. Toxicol. Pharmacol. 38:378-388.
5. Schecter, A., Birnbaum, L., Ryan, J.J., and Constable, J.D. (2006). Dioxins: an overview. Environ. Res. 101(3):419-428.
6. Grassman, J.A., Masten, S.A., Walker, N.J., and Lucier, G.W. (1998). Animal models of human response to dioxins. Environ. Health Perspect. 106(Suppl 2):761-775.
7. Safe, S.H. (1995). Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Ther. 67(2):247-281.
8. Long, W.P. and Perdew, G.H. (1999). Lack of an absolute requirement for the native aryl hydrocarbon receptor (AhR) and AhR nuclear translocator transactivation domains in protein kinase C-mediated modulation of the AhR pathway. Arch. Biochem. Biophys. 371(2):246-259.
9. Kim, S.Y. and Yang, J.H. (2005). Neurotoxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in cerebellar granule cells. Exp. Mol. Med. 37(1):58-64.
10. Mandal, P.K. (2005). Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J. Comp. Physiol. [B] 175(4):221-230.
11. Gannon, M., Gilday, D., and Rifkind, A.B. (2000). TCDD induces CYP1A4 and CYP1A5 in chick liver and kidney and only CYP1A4, an enzyme lacking arachidonic acid epoxygenase activity, in myocardium and vascular endothelium. Toxicol. Appl. Pharmacol. 164(1):24-37.
12. Abbott, B.D. and Probst, M.R. (1995). Developmental expression of two members of a new class of transcription factors: II. Expression of aryl hydrocarbon receptor nuclear translocator in the C57BL/6N mouse embryo. Dev. Dyn. 204(2):144-155.
13. Matsumura, F. (1994). How important is the protein phosphorylation pathway in the toxic expression of dioxin-type chemicals? Biochem. Pharmacol. 48(2):215-224.
14. Bombick, D.W, Jankun, J., Tullis, K., and Matsumura, F. (1988). 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains. Proc. Natl. Acad. Sci. USA 85(12):4128-4132.
15. DePetrillo, P.B. and Kurl, R.N. (1993). Stimulation of protein kinase C by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rat thymocytes. Toxicol. Lett. 69(1):31-36.
16. Kelling, C.K., Menahan, L.A., and Peterson, R.E. (1987). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment on mechanical function of the rat heart. Toxicol. Appl. Pharmacol. 91(3):497-501.
17. Canga, L., Paroli, L., Blanck, T.J., Silver, R.B., and Rifkind, A.B. (1993). 2,3,7,8-tetrachlorodibenzo-p-dioxin increases cardiac myocyte intracellular calcium and progressively impairs ventricular contractile responses to isoproterenol and to calcium in chick embryo hearts. Mol. Pharmacol. 44(6):1142-1151.
18. Canga, L., Levi, R., and Rifkind, A.B. (1988). Heart as a target organ in 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity: decreased beta-adrenergic responsiveness and evidence of increased intracellular calcium. Proc. Natl. Acad. Sci. USA 85(3):905-909.
19. Fan, L., Ovadia, M., Friedman, D.M., and Rifkind, A.B. (2000). Ventricular preexcitation sensitive to flecainide in late stage chick embryo ECGs: 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs inotropic but not chronotropic or dromotropic responses to isoproterenol and confers resistance to flecainide. Toxicol. Appl. Pharmacol. 166(1):43-50.
20. Fukunaga, B.N., Probst, M.R., Reisz-Porszasz, S., and Hankinson, O. (1995). Identification of functional domains of the aryl hydrocarbon receptor. J. Biol. Chem. 270(49):29,270-29,278.
21. Jokinen, M.P., Walker, N.J, Brix, A.E., Sells, D.M., Haseman, J.K., and Nyska, A. (2003). Increase in cardiovascular pathology in female Sprague-Dawley rats following chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3,3′,4,4′,5-pentachlorobiphenyl. Cardiovasc. Toxicol. 3(4):299-310.
22. Ivnitski-Steele, I.D., Sanchez, A., and Walker, M.K. (2004). 2,3,7,8-tetrachlorodibenzo-p-dioxin reduces myocardial hypoxia and vascular endothelial growth factor expression during chick embryo development. Birth Defects Res. A Clin. Mol. Teratol. 70(2):51-58.
23. Calvert, G.M., Wall, D.K., Sweeney, M.H., and Fingerhut, M.A. (1998). Evaluation of cardiovascular outcomes among U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Environ. Health Perspect. 106(Suppl 2):635-643.
24. Steenland, K., Piacitelli, L., Deddens, J., Fingerhut, M., and Chang, L.I. (1999). Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Natl. Cancer Inst. 91(9):779-786.
25. Pesatori, A.C., Zocchetti, C., Guercilena, S., Consonni, D., Turrini, D., and Bertazzi, P.A. (1998). Dioxin exposure and non-malignant health effects: a mortality study. Occup. Environ. Med. 55(2):126-131.
26. Dalton, T.P., Kerzee, J.K., Wang, B., et al. (2001). Dioxin exposure is an environmental risk factor for ischemic heart disease. Cardiovasc. Toxicol. 1(4):285-298.
27. Firestone D. (1973). Etiology of chick edema disease. Environ. Health Perspect. 5:59-66.
28. Kociba, R.J., Keyes, D.G., Beyer, J.E., et al. (1978). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo- p-dioxin in rats. Toxicol. Appl. Pharmacol. 46(2):279-303.
29. Walker, M.K., Pollenz, R.S., and Smith, S.M. (1997). Expression of the aryl hydrocarbon receptor (AhR) and AhR nuclear translocator during chick cardiogenesis is consistent with 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced heart defects. Toxicol. Appl. Pharmacol. 143(2):407-419.
30. Hermansky, S.J., Holcslaw, T.L., Murray, W.J., Markin, R.S., and Stohs, S.J. (1988). Biochemical and functional effects of 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD) on the heart of female rats. Toxicol. Appl. Pharmacol. 95(2):175-184.
31. Brewster, D.W., Matsumura, F., and Akera, T. (1987). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on guinea pig heart muscle. Toxicol. Appl. Pharmacol. 89(3):408-417.
32. January, C.T. and Moscucci, A. (1992). Cellular mechanisms of early afterdepolarizations. Ann. NY Acad. Sci. 644:23-32.
33. Cranefield, P.F. (1977). Action potentials, afterpotentials, and arrhythmias. Circ. Res. 41:415-423.
34. January, C. and Fozzard, H.A. (1988). Delayed afterdepolarizations in heart muscle: mechanisms and relevance. Pharmacol. Rev. 40(3):219-227.
35. Fozzard, H.A. (1992). Afterdepolarizations and triggered activity. Basic Res. Cardiol. 87(Suppl 2):105-113.
36. Song, Y. and Belardinelli, L. (1994). ATP promotes development of afterdepolarizations and triggered activity in cardiac myocytes. Am. J. Physiol. 267(5 Pt 2):H2005-H2011.
37. Volders, P.G., Vos, M.A., Szabo, B., et al. (2000). Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. Cardiovasc. Res. 46(3):376-392.
38. Choi, B.R., Burton, F., and Salama, G. (2002). Cytosolic Ca2+ triggers early afterdepolarizations and Torsade de Pointes in rabbit hearts with type 2 long QT syndrome. J. Physiol. 543(Pt 2):615-631.
39. Volders, P.G., Kulcsar, A., Vos, M.A., et al. (1997). Similarities between early and delayed afterdepolarizations induced by isoproterenol in canine ventricular myocytes. Cardiovasc. Res. 34(2):348-359.
40. Dessertenne, F. (1966). Ventricular tachycardia with 2 variable opposing foci. Arch. Mal. Coeur Vaiss. 59(2):263-272.
41. Pogwizd, S.M., McKenzie, J.P., and Cain, M.E. (1998). Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation 98(22):2404-2414.
42. Verkerk, A.O., Veldkamp, M.W., Baartscheer, A., et al. (2001). Ionic mechanism of delayed afterdepolarizations in ventricular cells isolated from human end-stage failing hearts. Circulation 104(22):2728-2733.
43. Wit, A.L. and Rosen, M.R. (1992). Afterdepolarizations and triggered activity: distinction from automaticity as an arrhythmogenic mechanism, in The Heart and Cardiovascular System, 2nd ed. (Fozzard, H.A., Haber, E., Jennings, R.B., et al., eds.). Raven, New York: pp. 2113-2163.
44. Tatsukawa, Y., Arita, M., Kiyosue, T., Mikuriya, Y., and Nasu, M. (1993). A comparative study of effects of isoproterenol and dihydroouabain on calcium transients and contraction in cultured rat ventricular cells. J. Mol. Cell Cardiol. 25(6):707-720.
45. Aomine, M., Tatsukawa, Y., Yamato, T., and Yamasaki, S. (1999). Antiarrhythmic effects of magnesium on rat papillary muscle and guinea pig ventricular myocytes. Gen. Pharmacol. 32(1):107-114.
46. Sah, R., Ramirez, R.J., Kaprielian, R., and Backx, P.H. (2001). Alterations in action potential profile enhance excitation-contraction coupling in rat cardiac myocytes. J. Physiol. 533(Pt 1):201-214.
47. 2+ release by voltage-clamp pulse duration in potentiated guinea-pig ventricular myocytes. J. Physiol. 480 (Pt 3):423-438.
48. Lederer, W.J. and Tsien, R.W. (1976). Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibres. J. Physiol. 263(2):73-100.
49. Kass, R.S., Tsien, R.W., and Weingart, R. (1978). Ionic basis of transient inward current induced by strophanthidin in cardiac Purkinje fibres. J. Physiol. 281:209-226.
50. Bers, D.M. and Ziolo, M.T. (2001). When is cAMP not cAMP? Effects of compartmentalization. Circ. Res. 89(5):373-375.
51. Karagueuzian, H.S. and Chen, P.S. (2001). Cellular mechanism of reentry induced by a strong electrical stimulus: implications for fibrillation and defibrillation. Cardiovasc. Res. 50(2):251-262.
52. Zygmunt, A.C. (1994). Intracellular calcium activates a chloride current in canine ventricular myocytes. Am. J. Physiol. 267(5 Pt 2):H1984-H1995.
53. Tiaho, F., Piot, C., Nargeot, J., and Richard, S. (1994). Regulation of the frequency-dependent facilitation of L-type Ca2+ currents in rat ventricular myocytes. J. Physiol. 477(Pt 2):237-251.
54. Bennett, P.B. and Begenisich, T.B. (1987 Catecholamines modulate the delayed rectifying potassium current (IK) in guinea pig ventricular myocytes. Pflugers Arch. 410(1-2):217-219.
55. Harvey, R.D., Clark, C.D., and Hume, J.R. (1990). Chloride current in mammalian cardiac myocytes. Novel mechanism for autonomic regulation of action potential duration and resting membrane potential. J. Gen. Physiol. 95(6):1077-1102.
56. Schramm, M., Thomas, G., Towart, R., and Franckowiak, G. (1983). Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature 303(5917):535-537.
57. Swynghedauw, B. (1991). Remodeling of the heart in chronic pressure overload. Basic Res. Cardiol. 86(Suppl 1):99-105.
58. Baartscheer, A., Schumacher, C.A., Belterman, C.N., Coronel, R., and Fiolet, J.W. (2003). [Na+]i and the driving force of the Na+/Ca2+-exchanger in heart failure. Cardiovasc. Res. 57(4):986-995.
59. Hanneman, W.H., Legare, M.E., Barhoumi, R., Burghardt, R.C., Safe, S., and Tiffany-Castiglioni, E. (1996). Stimulation of calcium uptake in cultured rat hippocampal neurons by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 112(1):19-28.